Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference

Rhea-AI Summary

Agile Therapeutics (Nasdaq: AGRX) announced that its Chairman and CEO, Al Altomari, will participate in a fireside chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference. The event will be available for on-demand listening starting January 11, 2021, at 6:00 AM Eastern Time on the Investors section of Agile's website. An archived version will remain accessible for 30 days. Agile Therapeutics focuses on women's healthcare, with its initial product, Twirla, a non-daily prescription contraceptive patch, utilizing proprietary Skinfusion technology.

PRINCETON, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced Chairman and Chief Executive Officer Al Altomari will participate in a fireside chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference.

The fireside chat will be available for on-demand listening beginning Monday, January 11, 2021, at 6:00 AM Eastern Time on the Investors section of the Agile Therapeutics website at www.agiletherapeutics.com, under the Events & Presentations tab. The archived webcast will be available for 30 days.

About Agile Therapeutics, Inc.
Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women.  Our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method.  Our initial product, Twirla^®, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion^®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website.

Follow Agile on LinkedIn and Twitter: @AgileTher.

Contact:  
Matt Riley
Head of Investor Relations & Corporate Communications
mriley@agiletherapeutics.com

FAQ

When will Agile Therapeutics participate in the H.C. Wainwright BIOCONNECT 2021 Virtual Conference?

Agile Therapeutics will participate in the conference on January 11, 2021.

How can I listen to the Agile Therapeutics fireside chat?

The fireside chat will be available on-demand starting January 11, 2021, on the Investors section of Agile Therapeutics' website.

What is Twirla and how does it relate to Agile Therapeutics?

Twirla is a non-daily prescription contraceptive patch developed by Agile Therapeutics, designed for women's healthcare.

What technology does Twirla use?

Twirla utilizes Agile Therapeutics' proprietary Skinfusion technology for drug delivery through the skin.

How long will the fireside chat be available for listening?

The archived webcast of the fireside chat will be available for 30 days.